pyrazinamide has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, M | 1 |
| Sugimoto, K | 1 |
| Yagi, K | 1 |
| Yanagida, H | 1 |
| Tabata, N | 1 |
| Takemura, T | 1 |
1 other study available for pyrazinamide and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
A boy undergoing maintenance hemodialysis who developed mediastinal lymph node tuberculosis.
Topics: Child; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Humans; Isoniazid; Lymph Node | 2006 |